Moxifloxacin impurity 160 CAS 1415319-29-7

Description

Compared with other compounds in its class, the molecular weight of 231.25 g/mol gives Moxifloxacin impurity 160 distinctive chromatographic separation conditions and mass-spectrometry parameter settings.

CATO supplies Moxifloxacin impurity 160 (CAS 1415319-29-7), a pharmacopoeial impurity reference standard (molecular formula C13H13NO3, MW 231.25 g/mol) used for the identification and quantification of trace impurities in APIs.

The molecular framework of Moxifloxacin impurity 160 (C13H13NO3) is characterized by a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage. In reversed-phase chromatography, its retention is governed primarily by its high hydrophobicity (logP), which provides a practical basis for HPLC-UV/DAD or LC-MS method development. Nitrogen-containing functional groups confer excellent ionization efficiency in positive-ion electrospray (ESI) mode, making the compound well suited to LC-MS/MS analysis.

This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.

As a certified reference material (CRM), Moxifloxacin impurity 160 meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.

Physical & Chemical Properties

Why CATO?

• ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
• 130,000+ catalog items in stock, COA supplied with every batch
• Worldwide shipping with full export documentation (HS code guidance available)
• Technical support: +86 18665070610 / Nicole.chen@cato-chem.com